PomDoctor Limited (POM)
PomDoctor will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
5,000,004
Deal Size
$25.00M
CTI BioPharma Revenue
PomDoctor had revenue of 327.19M CNY in the twelve months ending June 30, 2024. In the year 2023, PomDoctor had annual revenue of 304.85M with 24.32% growth.
Revenue (ttm)
327.19M CNY
Revenue Growth
+24.32%
P/S Ratio
13.15
Revenue / Employee
2,124,586 CNY
Employees
154
Market Cap
592.22M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 304.85M | 59.64M | 24.32% |
| Dec 31, 2022 | 245.22M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPOM News
- 10 days ago - PomDoctor Files For Nasdaq IPO That May Be Overvalued - Benzinga
- 4 months ago - PomDoctor Begins $15 Million U.S. IPO Rollout - Seeking Alpha
- 5 months ago - Chinese online medical platform PomDoctor files for a $15 million US IPO - Renaissance Capital
- 5 months ago - Pomdoctor IPO Registration Document (F-1) - SEC